首页> 外文会议>Conference of the American College of Veterinary Internal Medicine >FELINE DRUG METABOLISM AND DISPOSITION: DIFFERENCES BETWEEN CATS AND DOGS AND OTHERSPECIES
【24h】

FELINE DRUG METABOLISM AND DISPOSITION: DIFFERENCES BETWEEN CATS AND DOGS AND OTHERSPECIES

机译:猫的药物代谢和性格:猫狗和别人之间的差异

获取原文

摘要

Although it is widely appreciated that cats respond differently to certain drugs when compared with other companion animal species, the causes of these differences are poorly understood. This lecture will critically evaluate evidence for altered drugeffects in cats, focusing on pharmacokinetic differences between cats, dogs and humans, and the molecular mechanisms underlying these differences.A review of published pharmacokinetic studies' indicate that acetaminophen, propofol, carprofen, and acetylsalicylic acid (aspirin) are cleared significantly more slowly in cats versus dogs and humans (Figure 1). All of these drugs are metabolized by conjugation. Cats lack the major phenol UDP-glucuronosyltransferase (UGT) enzymes, including UGT1A6 and UGT1A9, that glucuronidate acetaminophen and propofol (Figure 2a). Deficient glucuronidation may also explain slower carprofen clearance, although thereis no direct evidence for this. Table 1 lists drugs with direct evidence that they are glucuronidated more slowly, or with similar efficiency compared with most other mammalian species. Although pharmacology textbooks commonly state that sensitivity of cats to the effects of aspirin (and related salicylates) is a consequence of poor glucuronidation by cats, there is no evidence to support this. In fact, the main pathway for elimination of aspirin (and other salicylates) in most species is glycine conjugation of the salicylate to form salicylurate that is excreted in urine4. As shown in Figure 2b, cats readily excrete salicylate glucuronides in the urine but poorly eliminate salicylurate suggesting a deficiency in glycine conjugation. Cats are also deficient in several other conjugation enzymes, including N-acetyltransferase (NAT) 2 and thiopurine methyltransferase (TMPT)6'7. NAT2 deficiency may be the reason cats are more prone to developing methemoglobinemia rather than hepatotoxicity from acetaminophen8. TMPT deficiency may predispose cats to azathioprine toxicity. No evidence was found for slower elimination of drugs cleared by oxidation or unchanged into urine or bile. Piroxicam, an oxidized drug, was cleared much more rapidly in cats than humans and dogs, although the mechanism for this difference is unclear.
机译:虽然众所周知,与其他伴侣动物物种相比,猫对某些药物的反应不同,但这些差异的原因被理解得很差。本讲座将批判性地评估猫的改变的德国缺陷,专注于猫,狗和人类之间的药代动力学差异以及这些差异的分子机制。发表的药代动力学研究的审查表明乙酰氨基酚,异丙酚,储物丁香酸(在猫对狗和人类中显着清除了阿司匹林(图1)。所有这些药物都是通过缀合而代谢的。猫缺乏主要的苯酚UDP-葡糖醛糖蛋白酶(UGT)酶,包括UGT1a6和Ugt1a9,即葡糖醛酸乙酰氨酰基和异丙酚(图2a)。缺乏葡萄糖化也可能解释较慢的储物室清关,但没有直接证据。表1列出了具有直接证据的药物,与大多数其他哺乳动物物种相比,它们具有更慢的血糖,或与效率相似。虽然药理学教科书通常说明猫对阿司匹林(以及相关水杨酸盐)效果的敏感性是猫的葡萄糖尿酸不良的结果,但没有证据证明这一点。事实上,在大多数物种中消除阿司匹林(和其它水杨酸酯)的主要途径是水杨酸盐的甘氨酸缀合,形成在尿液中排出的水杨酸盐。如图2B所示,猫在尿液中易于排出水杨酸葡萄糖醛糖苷,但消除了甘氨酸缀合物的缺乏症的缺乏症。猫也缺乏几种其他共轭酶,包括n-乙酰基转移酶(NaT)2和硫嘌呤甲基转移酶(Tmpt)6'7。 NAT2缺乏可能是猫越来越容易发生甲虫血症,而不是来自乙酰氨基酚的肝毒性。 TMPT缺乏可能使猫倾向于氮噻嗪毒性。没有发现氧化清除或不变成尿液或胆汁清除的药物较慢的证据。氧化药物,氧化药物的紫罗兰胺比人类和狗更迅速地清除,尽管这种差异的机制尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号